Litcius/Paper detail

Developing a routine lab test for absolute quantification of HER2 in FFPE breast cancer tissues using Quantitative Dot Blot (QDB) method

Guohua Yu, Wen‐Feng Zhang, Yunyun Zhang, Jiahong Lv, Shishou Wu, Xiaolong Sui, Jiandi Zhang, Fangrong Tang

2020Scientific Reports21 citationsDOIOpen Access PDF

Abstract

Developing immunoassay for absolute quantitation of protein biomarkers in Formalin Fixed Paraffin Embedded (FFPE) samples promises improved objectivity, consistency and accuracy in daily clinical practice. The feasibility of Quantitative Dot Blot (QDB) method for this purpose was explored in this study. We were able to measure HER2 protein levels using 0.5 µg/sample total protein lysate extracted from 2 × 5 µm FFPE slices absolutely and quantitatively using QDB method in 332 breast cancer FFPE samples. HER2 levels measured using two clinically validated antibodies for immunohistochemistry respectively were highly correlated (r = 0.963). We also achieved area under the curve (AUC) at 0.9998 ± 0.0002 (p < 0.0001, n = 224) with IHC analysis, and 0.9942 ± 0.0031 (p < 0.0001, n = 319) with combined results from IHC and Fluorescence in situ hybridization (FISH) analyses when analyzed with Receiver Operative Characteristics analysis (ROC) respectively. When the results were converted dichotomously with optimized cutoffs from ROC analyses, we achieved 99.5% concordance with IHC; and 96.9% with combined results from both IHC and FISH analyses. Therefore, we were able to demonstrate QDB method as the first immunoassay platform for absolute quantitation of protein biomarkers in FFPE samples to meet the need of daily clinical practice, especially for local laboratories or laboratories in developing countries.

Topics & Concepts

ConcordanceImmunohistochemistryImmunoassayBreast cancerMolecular biologyWestern blotFish <Actinopterygii>Receiver operating characteristicGold standard (test)Clinical PracticeDot blotAntibodyMedicinePathologyCancerChemistryBiologyInternal medicineImmunologyBiochemistryGeneFamily medicineFisheryAdvanced Biosensing Techniques and ApplicationsMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer Research